Baseline serum albumin levels ≥4.7 g/dl were associated with a significantly lower risk of coronary heart disease compared to levels <4.4 g/dl (OR 0.45).
Case-Control (n=609)
Yes
Is higher baseline serum albumin level associated with a reduced risk of coronary heart disease and myocardial infarction?
Higher baseline serum albumin levels are independently associated with a significantly lower risk of coronary heart disease and myocardial infarction.
Effect estimate: OR 0.45
The relation between serum albumin levels and subsequent incidence of myocardial infarction and coronary heart disease deaths was evaluated using stored serum from the Multiple Risk Factor Intervention Trial (MRFIT). There were 91 coronary heart disease deaths, 113 myocardial infarction patients, and 405 controls matched to cases within 5 years of age, treatment group, and clinic site. There was a highly significant inverse relation between serum albumin level and risk of coronary heart disease. Individuals with a baseline level of serum albumin greater than or equal to 4.7 g/dl had an odds ratio of 0.45 as compared with individuals with a baseline level of serum albumin less than 4.4 g/dl. The relation persisted after adjusting for other cardiovascular risk factors (blood pressure, smoking, and serum cholesterol). The association was stronger for coronary heart disease deaths than for surviving myocardial infarction patients, and for cigarette smokers as compared with cigarette nonsmokers. The deaths studied occurred in the time period at least 6 years after the sera had been obtained and up to 10.5 years of follow-up, and the myocardial infarctions studied occurred within the first 6.5 years of follow-up. There was no consistent relation between time and death due to coronary heart disease or myocardial infarction and albumin levels. Albumin levels are related to the acute phase reaction. Lower albumin levels may be a marker of persistent injury to arteries and progression of atherosclerosis and thrombosis. The consistent relation between albumin and coronary heart disease risk requires further evaluation.
Kuller et al. (1991) conducted a case-control in Coronary heart disease (n=609). Serum albumin level ≥4.7 g/dl vs. Serum albumin level <4.4 g/dl was evaluated on Incidence of myocardial infarction and coronary heart disease deaths (OR 0.45). Baseline serum albumin levels ≥4.7 g/dl were associated with a significantly lower risk of coronary heart disease compared to levels <4.4 g/dl (OR 0.45).